GRI Bio, Inc.
GRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001824293
No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $164.7K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding GRI Bio, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 526.5K | 579.3K | +52.8K (+10.0%) |
| Value | $2.44M | $3.15M | +$711.0K (+29.2%) |
New holders (5)
Institutions that held GRI Bio, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Murchinson Ltd. | 194,900 | $1.06M | 0.39% |
| Zeke Capital Advisors, LLC | 30,000 | $163.0K | 0.01% |
| Geode Capital Management, LLC | 13,116 | $71.0K | 0.00% |
| UBS Group AG | 813 | $4.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 17 | $0 | 0.00% |
Sold out (4)
Institutions that held GRI Bio, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Millennium Management LLC | 28,461 | $132.0K |
| AIGH Capital Management LLC | 20,514 | $95.0K |
| Sowell Financial Services LLC | 5,868 | $23.0K |
| BlackRock Inc. | 641 | $3.00K |